Urinalysis Results in Healthy Individuals

Sponsor
Kendall Healthcare Group, Ltd. (Industry)
Overall Status
Completed
CT.gov ID
NCT04055675
Collaborator
(none)
200
1
6
33.3

Study Details

Study Description

Brief Summary

This is a prospective, observational study assessing the results of urine dipsticks on adult volunteers with no acute symptoms. We seek to determine the frequency of leukocytes or nitrites in this group of individuals.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Urine dipstick test

Detailed Description

The urinalysis (UA) is one of the most commonly utilized tests in the emergency department (ED). In some busy EDs, a UA is routinely ordered by protocol on patients with abdominal pain, and in elderly patients, a UA is often ordered for a variety of chief complaints including dizziness and altered mental status. When these patients, who often do not specifically have symptoms of a urinary tract infection, have a urinalysis demonstrating pyuria or bacteria, it may be interpreted as an atypical presentation of a UTI. However, it is possible that these patients do not have urinary tract infections, but have baseline pyuria or bacteriuria. One prior study found that 5% of sexually active healthy women 18-40 have asymptomatic bacteriuria [1], and the rate of asymptomatic bacteriuria increases with age, such that it is present in 8-10% of women from 70-80 years of age [2]. Moreover, one prior article stated that 30-50% of residents of long term nursing facilities have positive urine cultures at any given time [3].

The above statistics come from the results of urine cultures. In the ED, the decision to treat or not treat a patient for a UTI is not made based upon culture results, but upon a urinalysis (microscopic or dipstick). Only one prior study has looked at the frequency of abnormal urinalyses in healthy individuals, and it found that over a third of asymptomatic women had at least 1+ leukocytes in their urine [4]. This is evidence that a substantial number of people who do not have symptomatic UTIs have UAs that could be interpreted as UTIs. If these results could be replicated and expanded to include a wider group of individuals (males, elderly patients, various races, etc.), it would provide valuable information about how we can better interpret and utilize the results of a UA.

Thus, the investigators propose a prospective study to assess the frequency of abnormal UAs in a wide variety of individuals without acute symptoms.

Urine samples will be obtained from adults with no acute symptoms, and performed urine dipsticks to assess the frequency of leukocytes or nitrites in the urine. Patients will be divided into groups to determine if there are certain factors (gender, age, or medical history) that increase the chance of having leukocytes or nitrites in the urine.

Study Design

Study Type:
Observational
Actual Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Frequency of Leukocytes and Nitrites in the Urine of Healthy Adults
Actual Study Start Date :
Jul 3, 2019
Actual Primary Completion Date :
Dec 30, 2019
Actual Study Completion Date :
Jan 2, 2020

Arms and Interventions

Arm Intervention/Treatment
Asymptomatic Male Volunteers

These are subjects over the age of 18 who have no acute symptoms, volunteered to provide a urine sample, and are male.

Diagnostic Test: Urine dipstick test
A sample of urine will be tested using a Mission Urinalysis Reagent Strip.

Asymptomatic Female Volunteers

These are subjects over the age of 18 who have no acute symptoms, volunteered to provide a urine sample, and are female.

Diagnostic Test: Urine dipstick test
A sample of urine will be tested using a Mission Urinalysis Reagent Strip.

Outcome Measures

Primary Outcome Measures

  1. False Positive Urine [The urine is tested immediately, and results are available two minutes after placing the reagent strip in the urine.]

    A urine sample with at least 1+ leukocytes or positive nitrites on urine dipstick test will be considered a "false positive urine".

Secondary Outcome Measures

  1. Incidental Hematuria [The urine is tested immediately, and results are available two minutes after placing the reagent strip in the urine.]

    A urine sample with any blood on urine dipstick test will be considered to have "incidental hematuria"

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age > 18 years

  • Able to spontaneously provide a urine sample

Exclusion Criteria:
  • Any acute symptoms (including but not limited to vaginal bleeding, vaginal discharge, abdominal pain, back pain, dysuria, hematuria, and fever)

  • Pregnancy

  • Prisoner status

  • Antibiotics within 72 hours

  • Urologic procedure within a week

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kendall Regional Medical Center Miami Florida United States 33175

Sponsors and Collaborators

  • Kendall Healthcare Group, Ltd.

Investigators

  • Study Director: Tony Zitek, MD, Nova Southeastern University

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
Kendall Healthcare Group, Ltd.
ClinicalTrials.gov Identifier:
NCT04055675
Other Study ID Numbers:
  • 2019-356 Non-NSU Health
First Posted:
Aug 14, 2019
Last Update Posted:
Jun 18, 2020
Last Verified:
Jun 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Asymptomatic Male Volunteers Asymptomatic Female Volunteers
Arm/Group Description These are subjects over the age of 18 who have no acute symptoms, volunteered to provide a urine sample, and are male. Urine dipstick test: A sample of urine will be tested using a Mission Urinalysis Reagent Strip. These are subjects over the age of 18 who have no acute symptoms, volunteered to provide a urine sample, and are female. Urine dipstick test: A sample of urine will be tested using a Mission Urinalysis Reagent Strip.
Period Title: Overall Study
STARTED 96 104
COMPLETED 96 104
NOT COMPLETED 0 0

Baseline Characteristics

Arm/Group Title Asymptomatic Male Volunteers Asymptomatic Female Volunteers Total
Arm/Group Description These are subjects over the age of 18 who have no acute symptoms, volunteered to provide a urine sample, and are male. Urine dipstick test: A sample of urine will be tested using a Mission Urinalysis Reagent Strip. These are subjects over the age of 18 who have no acute symptoms, volunteered to provide a urine sample, and are female. Urine dipstick test: A sample of urine will be tested using a Mission Urinalysis Reagent Strip. Total of all reporting groups
Overall Participants 96 104 200
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
46.2
(21.7)
53.7
(23.6)
50.1
(23.0)
Sex: Female, Male (Count of Participants)
Female
0
0%
104
100%
104
52%
Male
96
100%
0
0%
96
48%
Race (NIH/OMB) (Count of Participants)
American Indian or Alaska Native
0
0%
0
0%
0
0%
Asian
6
6.3%
4
3.8%
10
5%
Native Hawaiian or Other Pacific Islander
0
0%
0
0%
0
0%
Black or African American
4
4.2%
4
3.8%
8
4%
White
86
89.6%
96
92.3%
182
91%
More than one race
0
0%
0
0%
0
0%
Unknown or Not Reported
0
0%
0
0%
0
0%
Region of Enrollment (participants) [Number]
United States
96
100%
104
100%
200
100%

Outcome Measures

1. Primary Outcome
Title False Positive Urine
Description A urine sample with at least 1+ leukocytes or positive nitrites on urine dipstick test will be considered a "false positive urine".
Time Frame The urine is tested immediately, and results are available two minutes after placing the reagent strip in the urine.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Asymptomatic Male Volunteers Asymptomatic Female Volunteers
Arm/Group Description These are subjects over the age of 18 who have no acute symptoms, volunteered to provide a urine sample, and are male. Urine dipstick test: A sample of urine will be tested using a Mission Urinalysis Reagent Strip. These are subjects over the age of 18 who have no acute symptoms, volunteered to provide a urine sample, and are female. Urine dipstick test: A sample of urine will be tested using a Mission Urinalysis Reagent Strip.
Measure Participants 96 104
Count of Participants [Participants]
6
6.3%
40
38.5%
2. Secondary Outcome
Title Incidental Hematuria
Description A urine sample with any blood on urine dipstick test will be considered to have "incidental hematuria"
Time Frame The urine is tested immediately, and results are available two minutes after placing the reagent strip in the urine.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title
Arm/Group Description

Adverse Events

Time Frame During urine specimen collection and survey completion (about 5 minutes)
Adverse Event Reporting Description No adverse events were expected given the nature of the study.
Arm/Group Title Asymptomatic Male Volunteers Asymptomatic Female Volunteers
Arm/Group Description These are subjects over the age of 18 who have no acute symptoms, volunteered to provide a urine sample, and are male. Urine dipstick test: A sample of urine will be tested using a Mission Urinalysis Reagent Strip. These are subjects over the age of 18 who have no acute symptoms, volunteered to provide a urine sample, and are female. Urine dipstick test: A sample of urine will be tested using a Mission Urinalysis Reagent Strip.
All Cause Mortality
Asymptomatic Male Volunteers Asymptomatic Female Volunteers
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/96 (0%) 0/104 (0%)
Serious Adverse Events
Asymptomatic Male Volunteers Asymptomatic Female Volunteers
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/96 (0%) 0/104 (0%)
Other (Not Including Serious) Adverse Events
Asymptomatic Male Volunteers Asymptomatic Female Volunteers
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/96 (0%) 0/104 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. Tony Zitek
Organization Kendall Regional Medical Center
Phone 305-480-6602
Email zitek10@gmail.com
Responsible Party:
Kendall Healthcare Group, Ltd.
ClinicalTrials.gov Identifier:
NCT04055675
Other Study ID Numbers:
  • 2019-356 Non-NSU Health
First Posted:
Aug 14, 2019
Last Update Posted:
Jun 18, 2020
Last Verified:
Jun 1, 2020